SPT-300 (GlyphAllo)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SPT-300 (GlyphAllo), covering 2026-03-24 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study) [Phase 2]